Decoy Therapeutics (DCOY) Profit After Tax (2015 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Profit After Tax of -$2.2 million for Q1 2026, down 30.13% year-over-year from -$3.2 million in Q1 2025, and up 75.22% quarter-over-quarter from -$9.0 million in Q4 2025.
Decoy Therapeutics (DCOY) Profit After Tax (2015 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Profit After Tax for 12 consecutive years, with -$2.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Profit After Tax fell 30.13% year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at -$13.0 million (down 134.0% YoY), while the FY2025 annual figure was -$12.5 million, down 124.52% from the prior year.
- Profit After Tax grew to -$2.2 million in Q1 2026 per DCOY's latest filing, from -$9.0 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$873467.0 in Q3 2025 and bottomed at -$14.4 million in Q3 2022.
- Historically, Profit After Tax has averaged -$3.8 million across 5 years, with a median of -$2.2 million in 2026.
- Annual changes were most pronounced in 2023 — Profit After Tax soared 86.16% — and 2025, when it tumbled 513.26%.
- Decoy Therapeutics' Profit After Tax stood at -$6.4 million in 2022, then jumped by 86.16% to -$881796.0 in 2023, then slumped by 66.02% to -$1.5 million in 2024, then sank by 513.26% to -$9.0 million in 2025, then surged by 75.22% to -$2.2 million in 2026.
- Business Quant data shows DCOY's Profit After Tax at -$2.2 million in Q1 2026, -$9.0 million in Q4 2025, and -$873467.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Decoy Therapeutics | 1.75 Mn | 1.75 Mn | - | -2.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.37 Mn |
| Mar 31, 2026 | -2.22 Mn |
| Dec 31, 2025 | -8.98 Mn |
| Sep 30, 2025 | -873,467.00 |
| Jun 30, 2025 | -957,825.00 |
| Mar 31, 2025 | -1.71 Mn |
| Dec 31, 2024 | -1.46 Mn |
| Sep 30, 2024 | -972,121.00 |
| Jun 30, 2024 | -1.42 Mn |
| Mar 31, 2024 | -1.72 Mn |
| Dec 31, 2023 | -881,796.00 |
| Sep 30, 2023 | -2.44 Mn |
| Jun 30, 2023 | -3.88 Mn |
| Mar 31, 2023 | -5.34 Mn |
| Dec 31, 2022 | -6.37 Mn |
| Sep 30, 2022 | -14.41 Mn |
| Jun 30, 2022 | -4.72 Mn |
| Mar 31, 2022 | -6.11 Mn |
| Dec 31, 2021 | -4.10 Mn |
| Sep 30, 2021 | -3.74 Mn |